Plain-English translation of NCT06315179 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The STRIDE study is collecting biological samples—including blood, stool, urine, and tissue—from people who may have inflammatory bowel disease (like Crohn's disease or ulcerative colitis) or other digestive disorders. Researchers will analyze these samples to better understand what happens in the gut during these conditions and identify new ways to diagnose and treat them.
Doctors need better tools to understand why some people develop inflammatory bowel disease and how it differs from other digestive conditions that cause similar symptoms. This study aims to discover genetic and biological markers that could help doctors diagnose these illnesses faster and develop more targeted treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll participate in it alongside your regular clinical care for three years. During your scheduled medical visits, your doctor will collect samples as part of your normal evaluation—blood, stool, and tissue if needed—plus additional urine samples just for the research. You won't need extra visits beyond your regular appointments.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
Sponsor
Seattle Children's Hospital
Collaborators
Allen Institute
Enrollment target
~200 participants
Started
May 2024
Primary completion
January 2028
Age range
6 Years – 21 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mason E Nuding, BS
Seattle Children's Hospital, University of Washington
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.